Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.12
-0.02 (-0.28%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Instil Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.02 | 6.64 | 8.81 | 9.2 | 43.72 | 37.59 |
Short-Term Investments | 69.55 | 69.49 | 104.51 | 141.16 | 217.2 | 416.51 |
Cash & Short-Term Investments | 74.57 | 76.13 | 113.32 | 150.36 | 260.92 | 454.1 |
Cash Growth | -28.06% | -32.82% | -24.64% | -42.38% | -42.54% | 87.87% |
Other Current Assets | 113.73 | 115.3 | 11.16 | 10.4 | 8.46 | 9.92 |
Total Current Assets | 188.3 | 191.43 | 124.47 | 160.76 | 269.38 | 464.02 |
Net Property, Plant & Equipment | 0.17 | 0.36 | 130.34 | 141.07 | 209.34 | 122 |
Other Intangible Assets | - | - | - | - | - | 10.1 |
Goodwill | - | - | - | - | - | 5.72 |
Long-Term Investments | - | - | - | 23.16 | - | - |
Other Long-Term Assets | 11.95 | 11.73 | 8.76 | 0.64 | 3.41 | 8.14 |
Total Assets | 200.43 | 203.52 | 263.57 | 325.63 | 482.13 | 609.98 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.79 | 0.78 | 0.66 | 1.21 | 2.36 | 5.57 |
Other Current Liabilities | 3.93 | 4.06 | 7.24 | 9.35 | 30.07 | 34.45 |
Total Current Liabilities | 4.72 | 4.84 | 7.9 | 10.56 | 32.79 | 41.36 |
Long-Term Debt | 85 | 84.81 | 84.19 | 81.43 | 72.35 | - |
Long-Term Leases | - | - | 1.02 | 2.88 | 5.17 | - |
Other Long-Term Liabilities | 0.01 | 0.01 | 1.03 | 4.94 | 8.57 | 14.77 |
Total Long-Term Liabilities | 85.01 | 84.81 | 86.24 | 89.24 | 86.1 | 14.77 |
Total Liabilities | 89.73 | 89.66 | 94.13 | 99.8 | 118.52 | 54.78 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Additional Paid-in Capital | 841.92 | 840.94 | 824.78 | 807.16 | 788.99 | 757 |
Accumulated Other Comprehensive Income | -0.53 | -0.58 | -0.23 | -0.35 | -0.49 | -0.09 |
Retained Earnings | -730.69 | -726.49 | -655.12 | -580.98 | -424.89 | -201.72 |
Shareholders' Equity | 110.7 | 113.87 | 169.44 | 225.83 | 363.61 | 555.2 |
Total Liabilities & Equity | 200.43 | 203.52 | 263.57 | 325.63 | 482.13 | 609.98 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 85 | 84.81 | 85.2 | 84.3 | 77.52 | 0 |
Net Cash (Debt) | -10.43 | -8.68 | 28.11 | 66.05 | 183.4 | 454.1 |
Net Cash Growth | - | - | -57.44% | -63.98% | -59.61% | 87.87% |
Net Cash Per Share | -1.55 | -1.30 | 4.32 | 10.16 | 28.32 | 85.69 |
Book Value | 110.7 | 113.87 | 169.44 | 225.83 | 363.61 | 555.2 |
Book Value Per Share | 16.45 | 17.08 | 26.03 | 34.72 | 56.15 | 104.76 |
Tangible Book Value | 110.7 | 113.87 | 169.44 | 225.83 | 363.61 | 539.37 |
Tangible Book Value Per Share | 16.45 | 17.08 | 26.03 | 34.72 | 56.15 | 101.78 |